lennernas_2

Recipharm appoints Hans Lennernäs to operating Board

pharmafile | February 5, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing Recipharm 

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors.

Lennernäs is a Professor of Biopharmaceutics at Uppsala University. He currently manages an IMI project entitled OrBiTo, which aims to improve oral drug delivery.

Lennernäs has served as the principal investigator in an extensive collaboration with the FDA, University of Michigan, US, and Medical Product Agency, Sweden over the course of  several years in which he developed a new guideline for the Biopharmaceutics Classification System.

Advertisement

In addition to his academic achievements, Dr Lennernäs  has built an entrepreneurial reputation  by cofounding  several companies including DuoCort Pharma AB, and LIDDS AB, whilst investing in a number of patents.

“I am very much looking forward to serving on the Board of directors at Recipharm Pharmaceutical Development AB,” Lennernäs commented.

“We are very pleased to welcome a Board member of Hans Lennernäs calibre,” remarked general manager Maria Lundberg.

“His track record of successfully inventing and developing several novel drug delivery systems that are currently in pre-clinical phase and in preparation for Phase I, II and III clinical trials, makes him an excellent addition to the Board.”

Related Content

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON

Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …

Recipharm designates Germany site as Centre of Excellence

The multi-product facility recently underwent significant renovations

handshake

Strategic alliance announced between Recipharm and Exela

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The …

The Gateway to Local Adoption Series

Latest content